with cancer. We are the global leader in precision targeting of PRAME , a target expressed in more than 50 cancers. Our cutting‑edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T‑cell Salary:$200k - $230k